CytomX Therapeutics, Inc. (CTMX) Profit Margin
CytomX Therapeutics, Inc. (CTMX) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | -391.54% |
| 2017-12-31 | -60.17% |
| 2018-12-31 | -142.19% |
| 2019-12-31 | -177.84% |
| 2020-12-31 | -64.59% |
| 2021-12-31 | -310.54% |
| 2022-12-31 | -186.82% |
| 2023-12-31 | -0.56% |
| 2024-12-31 | 23.08% |
| 2025-12-31 | -22.79% |
How CTMX compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc. | -0.20% |
| HROW | Harrow Inc Com | -1.89% |
| AZTA | Azenta Inc. | -9.39% |
| PRGO | Perrigo Company plc | -33.51% |
| NMTC | NeuroOne Medical Technologies Corporation | -39.63% |
These are five companies in the same sector as CTMX with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get CytomX Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("CTMX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CTMX | $3.47 | +0.87% | 0.54M |
| 3 | ||||
| 4 | ||||
| 5 |